Nkarta, Inc. (NKTX) Financial Statements (2026 and earlier)

Company Profile

Business Address 1150 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments276,279282,331289,687265,507267,354283,055
Cash and cash equivalent39,63460,11453,41452,59827,87356,960
Short-term investments236,645222,217236,273212,909239,481226,095
Receivables 2,000   2,500 
Prepaid expense 3,819   3,249 
Other current assets 2,414   2,735 
Other undisclosed current assets(2,000)6,9446,8846,044(2,500)7,095
Total current assets:282,512289,275296,571271,551273,338290,150
Noncurrent Assets
Operating lease, right-of-use asset34,42933,79535,07635,53236,01438,804
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization66,72168,18270,34172,62574,65876,231
Long-term investments and receivables16,10731,42141,61183,651110,392119,467
Long-term investments16,10731,42141,61183,651110,392119,467
Restricted cash and investments2,7432,7432,7432,7432,7432,743
Other noncurrent assets1,6971,8201,9704,5074,0584,639
Total noncurrent assets:121,697137,961151,741199,058227,865241,884
TOTAL ASSETS:404,209427,236448,312470,609501,203532,034
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13,28811,17810,50511,31612,22913,775
Accounts payable2,0891,4371,5101,4906381,937
Accrued liabilities13,28811,17810,50511,31612,22913,775
Other undisclosed accounts payable and accrued liabilities(2,089)(1,437)(1,510)(1,490)(638)(1,937)
Other undisclosed current liabilities8,9787,8108,4227,4406,6888,693
Total current liabilities:22,26618,98818,92718,75618,91722,468
Noncurrent Liabilities
Liabilities, other than long-term debt69,61870,34871,71773,04874,31078,693
Other liabilities8787878787 
Operating lease, liability69,53170,26171,63072,96174,22378,693
Total noncurrent liabilities:69,61870,34871,71773,04874,31078,693
Total liabilities:91,88489,33690,64491,80493,227101,161
Equity
Equity, attributable to parent312,325337,900357,668378,805407,976430,873
Common stock777777
Additional paid in capital960,219958,256956,483954,353951,519947,441
Accumulated other comprehensive income (loss)4075363626526741,714
Accumulated deficit(648,308)(620,899)(599,184)(576,207)(544,224)(518,289)
Total equity:312,325337,900357,668378,805407,976430,873
TOTAL LIABILITIES AND EQUITY:404,209427,236448,312470,609501,203532,034

Income Statement (P&L) ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues
(gain on Disposition of Assets for Financial Service Operations)
 51     
Gross profit: 51     
Operating expenses(30,961)(27,286)(27,186)(36,564)(30,923)(33,794)
Other undisclosed operating loss (51)     
Operating loss:(30,961)(27,286)(27,186)(36,564)(30,923)(33,794)
Nonoperating income3,5525,5714,2094,5814,9885,450
Investment income, nonoperating3,2963,8523,9704,3764,8945,453
Other nonoperating income (expense)2561,71923920594(3)
Net loss available to common stockholders, diluted:(27,409)(21,715)(22,977)(31,983)(25,935)(28,344)

Comprehensive Income ($ in thousands)

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net loss:(27,409)(21,715)(22,977)(31,983)(25,935)(28,344)
Comprehensive loss:(27,409)(21,715)(22,977)(31,983)(25,935)(28,344)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(129)174(290)(22)(1,040)1,977
Comprehensive loss, net of tax, attributable to parent:(27,538)(21,541)(23,267)(32,005)(26,975)(26,367)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: